Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease

Background and Aims: We evaluated the association between endoscopic outcomes following risankizumab induction and subsequent rates of hospitalization and surgery through 52 weeks of risankizumab (both doses) maintenance therapy in patients with Crohn’s disease (CD). Methods: Patients with moderatel...

Descrición completa

Detalles Bibliográficos

Principais autores:	Brian G. Feagan, Jean-Frederic Colombel, Remo Panaccione, Stefan Schreiber, Marc Ferrante, Koji Kamikozuru, Christopher Ma, Wan-Ju Lee, Jenny Griffith, Namita Joshi, Kristina Kligys, Jasmina Kalabic, Si Xuan, Marla Dubinsky
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2025-01-01
Series:	Gastro Hep Advances
Assuntos:	Clinical trials Crohn’s Disease Endoscopy Surgery
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2772572324001389
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!